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Immunological memory is a central feature of the immune system that can provide long-lived, 
specific protection against previously encountered diseases. Despite our increasingly complex 
understanding of the cellular players, we still do not fully understand the mechanisms underlying 
immunological memory, and therefore, how best to induce effective memory responses to many 
infectious diseases.
In the past two decades, significant progress has been made revealing the complexity of lymphocyte 
populations induced by infections. The use of T-cell receptor transgenic mice in adoptive transfer 
experiments and major histocompatibility complex tetramer reagents has enabled immunologists to 
track T cell responses in mice and humans from the naïve lineage through to memory and during 
recall of resting memory populations (1, 2). This has provided a wealth of information about T cell 
specificity, homeostasis, trafficking, and facilitated the definition of multiple subsets of memory 
T cells. At least three main subsets of memory T cells have been defined, including central memory 
(TCM), effector memory (TEM), and tissue-resident memory (TRM) T cells (3). Antigen inexperienced 
CD8 T cells with a memory phenotype have also been described and may contribute to immunity. 
As knowledge of T cell responses has advanced, our understanding of memory B cell and long-lived 
plasma cell formation within tissues has come a long way. With the application of B cell receptor 
transgenic mice and increasingly sophisticated tools to analyze responses in humans, new research is 
adding to a wealth of information on humoral immunity and memory to pathogens and vaccines (4).
A challenge for the field moving forward will be to better define memory lymphocyte subsets on 
the basis of function as well as phenotype, the relationships between subsets, and importantly how 
each correlate with protective immunity. This will be particularly crucial in humans, where T cell 
responses are commonly only examined in peripheral blood, whereas memory T cells, especially 
TRM cells, are highly compartmentalized within non-lymphoid tissues (5). Defining immunological 
memory in human tissues and determining how to induce circulating and tissue-resident lympho-
cytes through vaccination is an outstanding challenge for the field.
With technological advancements in intravital imaging and cell tracking, the cellular interac-
tions involved in the activation of T and B cells to vaccination and infection are becoming clearer 
(6). It will be important to better define the cellular interactions in lymphoid and non-lymphoid 
tissues that underlie the development and homeostasis of memory lymphocyte subsets. Both TRM 
cells and memory lymphocytes that transit from blood to tissues and back again are influenced by 
tissue microenvironments (7). As such, an important goal should be to define which signals imprint 
lymphocytes with the ability to develop into different memory subsets and that direct cells to reside 
in specific tissues and organs. This will be a vital step to combat many diseases, where mucosal, 
cutaneous, or nervous tissues serve as primary pathogen entry points. In addition, understanding 
the influence of the microbiome on the formation and maintenance of immunological memory 
is lacking but could hold substantial promise (8). Recent work highlighting differences between 
the memory compartments in experimental SPF mice with humans or outbred mice housed under 
2Mueller 
Frontiers in Immunology | www.frontiersin.org April 2017 | Volume 8 | Article 385
Grand Challenges in Immunological Memory
non-SPF conditions (pet store mice) also implicate a need to 
include models of immunological memory that better reflect that 
in humans (9).
Another area where significant progress continues to be made 
is in dissection of the molecular pathways required for memory 
lymphocyte development and function (10). Identification of 
key transcription factors and transcriptional networks will 
help in defining how we can better guide memory responses 
via vaccines and adjuvants. Likewise, how epigenetic modifica-
tions are induced and maintained within memory lymphocytes 
remains to be fully elucidated (11), but advances in the field are 
making such experiments with small populations of memory 
cells considerably easier. It will then be critical to determine 
whether pharmacological interventions to manipulate epigenetic 
pathways, including DNA methylation and histone acetylation, 
could provide therapeutic avenues to complement vaccination. 
In addition to this, we must consider the long-term changes to 
the metabolism of memory cells that can promote their func-
tions and possibly also persistence (12). Are metabolic changes 
attuned to tissue microenvironments and can we manipulate this 
for therapeutic gain?
How memory cells perform immunosurveillance functions 
and then rapidly respond upon antigen encounter within tis-
sues remains poorly understood and requires further study. 
Memory T and B  cell subsets each contribute to protection 
from reinfection, yet the relative roles of distinct subsets in the 
context of different infections and tissues are not clear. The ability 
to analyze single cells at the genomic and proteomic level may 
prove useful in this regard, as advanced tools to analyze “omics” 
data and detect differences within phenotypically homogeneous 
populations become more sophisticated. Also, the fate of memory 
lymphocytes that are restimulated regularly by pathogens is of 
particular relevance to human immunology. Such questions have 
proven extremely challenging, given the difficulty in following 
populations of memory cells across time and through multiple 
challenges. At a population level, studies have suggested that 
the memory compartment can increase in size substantially. 
Tellingly, many human tissues have substantial populations of 
memory lymphocytes (5). However, the fate of memory cells that 
are restimulated multiple times is not clear, either at the popula-
tion or single cell level. Since chronic antigenic stimulation can 
negatively impact on lymphocyte functions (13), it will be valu-
able to determine whether memory cells induced by infection or 
vaccination, which are repeatedly restimulated, retain the ability 
to quickly and efficiently deal with infections, and if not how we 
can overcome this.
Another question highly relevant to the field of immunologi-
cal memory is whether innate immune cells also acquire traits of 
memory cells after challenge (14). This is established for NK cells 
that can elicit antigen-specific memory functions in response to 
viral infection. It is less clear whether other innate lymphoid cell 
lineages will show similar traits. It is feasible that, like NK cells, 
many innate cells can be imprinted non-specifically by epigenetic 
mechanisms to elicit distinct responses upon recall. Whether this 
constitutes immunological memory will then need to be defined 
by the field.
The translational challenge that lies ahead is an ability to design 
new vaccines that can control infections and cancers, within highly 
diverse human populations. Though we have learnt much about 
how immune memory populations are formed and can function 
to protect against disease, the application of this knowledge to 
many pathogens remains elusive. The recent advances in the field 
of immunological memory provide plenty of scope for many of 
these questions to be answered in the near future.
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